Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tonix Pharmaceuticals Holding Corp. - Common Stock (NQ: TNXP )

15.00 +1.36 (+9.97%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 979,167
Open 13.50
Bid (Size) 14.97 (2)
Ask (Size) 15.15 (1)
Prev. Close 13.64
Today's Range 13.50 - 15.67
52wk Range 6.760 - 1,193.28
Shares Outstanding 186,894,225
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at 2025 BIO-Europe Spring Convention
Via Investor Brand Network
Exposures Product Safety

Performance

YTD
-52.23%
-52.23%
1 Month
+31.23%
+31.23%
3 Month
-71.70%
-71.70%
6 Month
+1.69%
+1.69%
1 Year
-98.54%
-98.54%

More News

Read More
Life Sciences Investor Forum Agenda Announced for March 13th
From Virtual Investor Conferences
Via GlobeNewswire
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Advances TNX-1500 to Address Organ Transplant Rejection
Via Investor Brand Network
Exposures Product Safety
Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target
Via ACCESS Newswire
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO to Present at Zacks SCR Life Sciences Virtual Forum
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Secures MCDC Grant for TNX-801 Smallpox and Mpox Vaccine Development
Via Investor Brand Network
Exposures Product Safety
Which stocks are moving on Thursday?
Via Chartmill
Top movers in Thursday's session
Via Chartmill
Tonix Pharmaceuticals (TNXP) Stock Is Up 115% This Week: What's Going On?
Via Benzinga
Here are the top movers in Wednesday's session.
Via Chartmill
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at 2025 Virtual Investor Summit
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Phase 3 Data on TNX-102 SL for Fibromyalgia
Via Investor Brand Network
Topics Emissions
What's Going On With Tonix Pharmaceuticals Shares Friday?
Via Benzinga
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Preliminary 2024 Financial Results
Via Investor Brand Network
Exposures Product Safety
Which stocks are moving on Thursday?
Via Chartmill
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Positive Phase 1 Results for TNX-1500 in Transplant and Autoimmune Therapy
Via Investor Brand Network
Exposures Product Safety
Here are the top movers in Wednesday's session.
Via Chartmill
What's going on in today's session
Via Chartmill
Tonix Pharma Dominates Retail Biotech Buzz After 1-for-100 Reverse Split, Sentiment Turns Neutral Amid Volatility
Via Stocktwits
The market is filled with gapping stocks in Wednesday's session.
Via Chartmill
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO to Present at BIO CEO & Investor Conference
Via Investor Brand Network
Exposures Product Safety
Top movers analysis one hour before the close of the markets on 2025-02-04: top gainers and losers in today's session.
Via Chartmill
Tuesday's session: most active stocks
Via Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session.
Via Chartmill
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.